期刊文献+

人胰岛素原DNA疫苗预防非肥胖糖尿病鼠胰岛β细胞凋亡的机制探讨 被引量:1

Mechanisms of human proinsulin DNA vaccine preventing islet beta-cell apoptosis in NOD mice
下载PDF
导出
摘要 目的探讨人胰岛素原DNA疫苗预防非肥胖糖尿病(NOD)小鼠胰岛β细胞凋亡的机制。方法(1)4周龄NOD雌鼠随机分为磷酸盐缓冲液(PBS)、质粒载体PcDNA3.1(PcDNA)、胰岛素原(PIns)3组,由胫前肌分别注射PBS、质粒PcDNA3.1、人胰岛素原DNA疫苗50μg,1周后重复1次。(2)各组取12周龄未发病的NOD鼠10只,分离胰腺,HE染色观察胰岛炎;TUNEL+SABC法检测胰岛β细胞凋亡;取脾制成细胞悬液培养72 h,ELISA法测定血清白介素4(IL-4)和γ干扰素(IFN-γ)水平;MTT法检测脾细胞增殖反应。结果(1)12周龄时PIns组正常胰岛比例高于PBS组和PcDNA组(均P<0.01),胰岛周围炎比例低于PcDNA组(P=0.02),胰岛内炎比例则低于PBS组(P<0.01)和PcDNA组(P=0.006);(2)PIns组胰岛β细胞凋亡率低于PBS组和PcD-NA组(均P<0.01);(3)PIns组血清IL-4/IFN-γ比值显著高于PBS组(P=0.014)和PcDNA组(P=0.036);(4)PIns组脾细胞对人胰岛素增殖反应的刺激指数(SI)低于PcDNA组(P=0.021)。结论人胰岛素原DNA疫苗通过上调IL-4/IFN-γ比值,使免疫平衡向Th2偏移,致NOD鼠胰岛炎减轻,胰岛β细胞凋亡减少。 Objective To investigate the mechanisms of human proinsulin DNA vaccine preventing islet β-cell apoptosis in NOD mice. Methods Female NOD mice at 4 weeks of age were randomly divided into PBS, pcDNA, and Pins groups. Mice in each group received two intramusclar injections of 0.05 ml of PBS alone, 50μg of pcDNA3.1 and 50μg of human proinsulin DNA vaccine emulsified in 0.05 ml PBS at day 1 and 8. Pancreas was removed from NOD mice at 12 weeks of age in each group (n= 10) to score insulitis severity by routine H-E staining. The apoptotic 13 cells in islets were observed with double-labeling technique of TUNEL in situ combined with standard sensitive avidin-biotin complex (sABC) immunohistochemical method. MTT was used for detecting spleen cell proliferative response to human insuln. IL-4 and IFN-γ levels in sera were measured by ELISA. Results (1) At 12 weeks of age, the ratio of infiltrated islet in Pins group was higher than that in PBS group (χ^2 =27.5, P〈0. 001) and pcDNA group (χ2 =21.8, P〈0. 001), the ratio of peri-insulitis was lower in Pins group than that in pcDNA group (χ^2 =5.4, P=0.02), the ratio of intraislet insulitis was lower in Pins group than that in PBS group (χ^2 =20. 1, P〈0.001) and pcDNA group (χ^2 =7.5, P= 0. 006) respectively. (2) The apoptotic β cell rates in Pins group was lower than that in PBS group(χ^2 =80.8, P〈0. 001) and pcDNA group (χ^2 =62.2, P〈0. 001). (3) The ratio of IL-4/ IFN-γ in sera was higher in Pins group than that in PBS (t=2.66, P=0.014) and pcDNA group(P=0.036) respectively. (4) The stimulative index (SI) of spleen cell to human insuln was lower in Pins group than that in pcDNA group (P=0. 021). Conclusion Human proinsulin DNA vaccine upregulating the ratio of IL-4/ IFN-γ makes Th cells deviate to Th2, and subsequently prevents insulitis and beta-cell apoptosis in NOD mice.
出处 《中华糖尿病杂志(1006-6187)》 CSCD 北大核心 2005年第5期383-385,共3页
基金 国家自然科学基金资助项目(30170440 30370681 39770352)
关键词 DNA疫苗 胰岛素原 胰岛炎 凋亡 小鼠 近交NOD DNA vaccine Proinsulin Insulitis Apoptosis Mice, inbred NOD
  • 相关文献

参考文献9

  • 1Eshima K, Mora C, Wong FS, et al. A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse. Int Immunol, 2003,15:351-357.
  • 2Wegmann DR, Eisenbarth GS. It's insulin. J Autoimmun,2000,15:286-291.
  • 3Coon B, An LL, Whitton L, et al. DNA immunization to prevent autoimmune diabetes. J Clin Invest, 1999,104:189-194.
  • 4Eizirik DL, Darville MI. Beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes, 2001,50(suppl 1): S64-S69.
  • 5蒋铁建,周智广,苏恒,罗建华.人胰岛素原DNA疫苗的构建与鉴定[J].科学技术与工程,2003,3(2):139-142. 被引量:2
  • 6裴剑浩,周智广,罗建华,蒋铁建,李霞,何凌.吡格列酮对非肥胖性糖尿病小鼠糖尿病的预防作用及机理探讨[J].中华医学杂志,2004,84(5):411-415. 被引量:18
  • 7French MB, Allison J, Cram DS, et al. Transgenic expression of mouse proinsulin Ⅱ prevents diabetes in nonobese diabetic mice. Diabetes,1997, 46: 34-39.
  • 8Tian J, Olcott AP, Hanssen LR, et al. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice. Immunol Rev, 1998, 164:119-127.
  • 9Mathis D, Vence L, Benoist C. Beta-Cell death during progression to diabetes. Nature, 2001, 414:792-798.

二级参考文献9

  • 1[1]Wegmann D R, Eisenbarth G S. It's insulin. J Autoimmun, 2000; 15:286-291
  • 2[2]Coon B, An L L, Whitton J L, et al. DNA immunization to prevent autoimmune diabetes. J Clin Invest, 1999; 104:189-194
  • 3[3]Dilts S M, Lafferty K J. Autoimmune diabetes: the involement of benign and malignant autoimmunity. J Autoimmun, 1999;12:229-232
  • 4[4]Komulainen J, Kulmala P, Savola K, et al. Clinical, autoimmune and genetic characteristics of very young children with type Ⅰ diabetes . Childhood diabetes in Finland (DiMe) study group. Diabetes Care, 1999;22: 1950-1955
  • 5[5]Potter K N, Wilkin T J. The molecular specificity of insulin autoantibodies.Diabetes Metab Res Rev, 2000;16:338-353
  • 6[6]French M B, Allison J, Cram D S, et al. Transgenic expression of mouse proinsulin Ⅱ prevents diabetes in nonobese diabetic mice. Diabetes, 1997;46:34-39
  • 7杨文,周智广,杨竹林,文建新,吴杨松,冯清泉.谷氨酸脱羧酶与完全弗氏佐剂预防鼠胰岛炎及糖尿病的探讨[J].中华医学杂志,1998,78(2):148-149. 被引量:5
  • 8李玉秀,王奔,孙琦,杨国华.NOD小鼠口服胰岛素对胰岛Fas及其配体表达的影响[J].中华内分泌代谢杂志,1999,15(2):72-76. 被引量:9
  • 9李霞,周智广,黄干,彭健,颜湘,王建平,杨琳.罗格列酮与胰岛素合用对LADA患者胰岛β细胞功能保护作用的初步观察[J].中国糖尿病杂志,2003,11(4):242-246. 被引量:63

共引文献18

同被引文献17

  • 1张程亮,向明,邹晓蕾,彭佳蓓.髓源性树突状细胞过继转移诱导1型糖尿病小鼠免疫耐受及其机制[J].世界华人消化杂志,2006,14(33):3175-3179. 被引量:4
  • 2Pietropaolo M, Surhigh JM, Nelson PW, et al. Primer: immunity and autoimmunitv. Diabetes.2008,57:2872-2882.
  • 3Tritt M, Sgouroudis E, Hennezel E, et al. Functional waning of naturally oecmTing CIM + regulatory T-cells contributes to the on- set of antoimmune. Diabetes ,2008,57 : 113-123.
  • 4Voharelli JC,Couri CE. Stem cell transplantation for type 1 diabe- tes mellitus. Diabetol Metab Syndr,2009,1 : 1-4.
  • 5Couri CE, Oliveira MC, Stracieri AB, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hem- atopoietic stem cell transplantation in newly diagnosed type 1 dia- betes mellitus. JAMA ,2009,301 : 1573-1579.
  • 6Allen JS, Pang K, Skowera A, et al. Plasmacytoid dendritic cell are proportionally expanded at dignosis of type 1 diabetes and en- hance islet autoantigen presentation to T-cells through immune complex capture. Diabetes ,2009,58 : 12-13.
  • 7Hubert P,Jacobs N, Caberg JH, et al. The cross-talk between den- dritil cells and regulatory T cells: good or evil? Leukoc Biol, 2007,82:781-794.
  • 8Skyler JS, krischer JP, Woltsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes : The Diabetes Prevention Trial-Type 1. Diabetes Care,2005,28 : 1068-1076.
  • 9Staeva-Vieira T, Peakmam M, yon Herrath M. Translational minire- view series on type 1 diabetes:immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol,2007,148 : 17-31.
  • 10Ludvigssion J. Therpy with GAD in diabetes. Diabetes Metab Res Rev, 2009,25 : 307 -315.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部